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Variant (Prinzmetal’s) angina is an uncommon cause of precordial pain caused by coronary vasospasm and characterized
by transient ST elevation and negative markers of myocardial necrosis. This is the case of a female patient with a prior
history of depression and panic attacks who presented with recurrent symptoms including chest pain. A cardiac event monitor
positively documented coronary vasospasm associated with anxiety-provoking chest pain, whereas the coronary arteries were
angiographicallynormal.Wenotedthatthefrequencyofanginaattacksapparentlyincreasedduringtheperiodthatcoincidedwith
the introduction of Bupropion SR for treatment of the patient’s depression. Considering the possibility of bupropion-associated
negative impact on coronary vasospasm, the antidepressant therapy was adjusted to exclude this drug. Although Prinzmetal’s
angina is relatively uncommon, we suspect that a routine use of cardiac event monitors in subjects with panic disorder might
reveal a greater incidence of coronary vasospasm in this patient population.
Copyright © 2009 Mladen I. Vidovich et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Almost one third of patients with chest pain who undergo
coronary angiography have no apparent arterial abnormal-
ities [1]. Some cases of such chest pain are diagnosed as
Prinzmetal’s, variant angina [2], in which pain typically
occurs at rest and is caused by intense coronary vasospasm
as opposed to typical angina, which is provoked by exercise
and is most commonly due to coronary atherosclerosis.
Frequently, when no coronary artery abnormalities are
found, chest pain may be associated and is often attributed
to panic disorder [3]. A history of the comorbidity of
psychiatric disorders in patients who present with chest pain
further complicates diagnostic and therapeutic decision-
making. Here we report the case of a patient with a history
of depression and anxiety who presented to the emergency
room with chest pain.
2.CaseReport
This is the case of 61-year-old African-American woman
withahistoryofdepressionandanxietywhopresentedtothe
emergency room in May 2008 with an acute episode of left-
sidedchestpain/pressurewithassociatedshortnessofbreath,
diaphoresis, and an impending sense of doom lasting 2-3
minutes. There was no identiﬁable precipitant to this event.
She was admitted and placed on a cardiac telemetry
monitoring. In the hospital, she was free of chest pain. The
electrocardiogram, telemetry, and serial cardiac enzymes did
not reveal myocardial infarction or any acute cardiac event.
There was no family history of coronary artery disease.
Medical history included hypertension, obesity, sleep apnea,
and a history of smoking (quit 10 years prior) and alcohol
abuse(fromage40to51).Duringhospitalization,thepatient
voiced concern that her chest pain may have been related
to a recent recurrence of depressive symptoms. She recalled
having similar chest pain 10 years ago. At that time, she had
had cardiac testing including angiography, which was nor-
mal,andthepainwasdiagnosedaspanicattacks.Atthattime
(10 years ago) some relief was provided by diazepam and
sertraline. As a young adult, the patient described low-level
depression with suicidal ideation. Her other past psychiatric
medications included ﬂuoxetine, buspirone, trazodone, and
risperidone. Her family psychiatric history included a father2 Cardiovascular Psychiatry and Neurology
(a)
(b)
Figure 1: Representative ECG recordings. Panel (a) shows the baseline ECG. Panel (b) shows ECG recordings during the chest pain and
reveals the ST segment elevations.
with depression, a brother with alcohol abuse, and one son
with depression, alcohol abuse, and completed suicide (7
years ago). At the time of hospitalization, the patient was
divorcedwithonelivingson.Atdischarge,shewasscheduled
for an outpatient stress test.
Six days after hospitalization, she was seen in the medical
clinic. She was free of chest pain but reported depression
with decreased energy, lethargy, and decreased interest in
activities. Therapy was started with 25mg of sertraline for
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was made to the psychiatry department.
One month after being started on sertraline (early June),
she was seen in psychiatry clinic. At that time, she was
tolerating 50mg of sertraline but without much beneﬁt. She
describeddepressionwithanergiaandalowerlevelofanxiety
thanshehadpreviouslyinpsychiatriccareyearsago.Shealso
reported 2 episodes of chest pain with tremor and sensation
of heart racing in the past month. Laboratory analyses were
ordered to rule out organic fatigue, and a referral was made
to a sleep clinic as she had been diagnosed with sleep apnea 8
years before by a polysomnogram (PSG) test, but failed to
follow up. Bupropion (Bupropion SR, 100mg) was added
to sertraline to address her depression with anergia, and
alprazolam was given for anxiety as needed. Two and a half
weeks after being started on bupropion the patient was still
complaining of depression and fatigue, and bupropion was
increased to 150mg.
Three weeks after the bupropion dose change, the PSG
results came back revealing sleep apnea, and the patient
was placed on continuous positive airway pressure (CPAP)
therapy. A week after PSG results were received, during her
sleep clinic appointment, the patient experienced substernal
chest pain with pressure radiating down her left arm.
The physician from the sleep clinic made a referral to
cardiology, as she had failed a previous appointment for
cardiology and a stress test. In a psychiatric follow-up (one
week after her sleep clinic appointment), she was feeling
much better, including improved mood and less fatigue and
anxiety.
One week later, the patient was seen in the cardi-
ology outpatient clinic describing a 3-month history of
frequent (10 or 15) episodes of severe midsternal chest
pain lasting 5 to 10 minutes that was associated with left
arm weakness. The symptoms were neither exercise-induced
nor predictable. The symptoms were extremely anxiety-
provoking but she reported no associated diaphoresis or
shortness of breath. The electrocardiogram revealed sinus
rhythm and left ventricular hypertrophy. The cholesterol
panel was unremarkable. Due to worrisome clinical presen-
tation, coronary angiography was performed. The coronary
arteries were angiographically normal. There were no wall
motion abnormalities, and the ejection fraction was normal.
The patient was discharged with a cardiac event monitor.
Within 5 days the patient experienced two recurrences of
her symptoms. The event monitor revealed ST elevations
that were associated with anxiety-provoking chest pain
(Figure 1). There were no signiﬁcant changes in heart
rate and no arrhythmias were recorded. The patient was
diagnosed with vasospastic (Printzmetal’s or variant) angina
and started on amlodipine (2.5mg daily) and isosorbide
mononitrate (30mg daily).
In a subsequent psychiatric follow-up, the patient was
free of chest pain and panic attacks. Bupropion was tapered
oﬀ, and sertraline was increased to 75mg daily because it
was feared that bupropion could contribute to or worsen her
coronary vasospasm.
3. Discussion
Prinzmetal’s-variant angina is an uncommon cause of pre-
cordial pains, characterized by transient ST elevation and
negative markers of myocardial necrosis [2, 4]. This type of
anginaiscausedbyanintensecoronaryvasospasmofunclear
etiology. A deﬁnitive diagnosis requires demonstration of
spontaneous or test-provoked (e.g., by hyperventilation,
acetylcholine, or ergonovine) ST-segment elevation. Based
on data from test-provoked vasospasms, the reported inci-
dence of variant angina ranges from 4% to 32% [5]. In ourCardiovascular Psychiatry and Neurology 3
patient, the spontaneous ST-segment elevation associated
with the anxiety-provoking chest pain was documented
using a cardiac event monitor.
There are no studies on the incidence of panic disorder
in patients with Prinzmetal’s angina/chest pain, but about
onethirdofchestpainpatientswithangiographicallynormal
coronary arteries reportedly have panic disorder [1, 6]. It
is worth noting that hyperventilation, a proposed provoca-
tive test for diagnosing Prinzmetal’s angina [7], typically
accompanies panic attacks and hence could trigger coronary
vasospasm in susceptible subjects. Although no systematic
research has been conducted on the occurrence of coronary
vasospasm in patients with panic disorder, several cases of
coronary vasospasm leading to ischemia were documented
in these patients [8]. These latter cases appear to be less
common in patients with panic disorder and bear similarity
to conditions of acute stress cardiomyopathy, also known as
Takotsubo cardiomyopathy or broken heart syndrome [9].
The case we present here is unusual because in addition
to documented Prinzmetal’s angina, the main psychiatric
component of the disorder presented as depression with
panic attacks rather than typical panic disorder. Further-
more, although the patient had been diagnosed with panic
attacks 10 years prior, chest pain was mostly absent until the
episodethatledtohermostrecenthospitalization.Moreover,
the frequency of angina attacks increased dramatically (up to
15 episodes in 3 months) during the period that coincided
with the introduction of bupropion for treatment of the
patient’s depression.
It has been suspected that bupropion may be associated
with chest pain [10] and myocardial infarction. In two
cases, young males were diagnosed with ST elevations,
normal coronary angiogram, and myocardial infarction,
which was associated with the use of bupropion [11, 12].
The main mechanism of bupropion’s action is believed to
be the inhibition of the central nervous system presynaptic
dopamine and norepinephrine reuptake transporters. In
addition, it appears that bupropion exerts a direct action
on the human myocardium, presumably by triggering cat-
echolamine release [13]. Since our patient had a diagnosis
of prior angina attacks, it is possible that her recent angina
could have been exacerbated by treatment with bupropion.
While majority of patients with Prinzmetal’s angina stabilize
and improve after the initial 3–6 month period of frequent
symptoms,recrudescencehasbeenobserved.Thetriggersfor
the return of symptoms have not been elucidated [14].
4. Conclusion
Thispatient,whohadapriorhistoryofdepressionandpanic
attacks, presented with recurrent symptoms including chest
pain. Using a cardiac event monitor, she was documented to
be suﬀering from coronary vasospasm that was associated
with anxiety-provoking chest pain. We noted that the
frequency of angina attacks apparently increased during the
period that coincided with the introduction of bupropion
for treatment of the patient’s depression. Considering the
possibility that bupropion may have a negative impact
on coronary vasospasm, the antidepressant therapy was
adjusted to exclude this drug. Although Prinzmetal’s angina
is relatively uncommon, further studies are needed to assess
the routine use of cardiac event monitor in subjects with
panic disorder. Furthermore, this case is a good example
of how a close collaboration between cardiologists and
psychiatrists can improve patient care.
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